Lv2
154 积分 2025-04-07 加入
Effects of SGLT2 inhibitors on angiography-derived coronary microcirculatory resistance and clinical outcomes in patients with coronary heart disease and type 2 diabetes: A cohort study
23天前
已完结
Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study
23天前
已完结
Assessment of myocardial perfusion with SPECT in obese patients with high and very high cardiovascular risk during GLP-1 receptor agonists therapy, preliminary results
23天前
已完结
Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction
23天前
已完结
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
1个月前
已完结
Empagliflozin in Patients with Chronic Kidney Disease
1个月前
已完结
Dapagliflozin in Patients with Chronic Kidney Disease
1个月前
已完结
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review
1个月前
已完结
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
1个月前
已完结
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
1个月前
已完结
皖公网安备34019202002308
